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The receptor tyrosine kinase (RTK) signaling network plays a central role in regulating cellular differentiation, proliferation,
and survival in all metazoan animals. Excessive or continuous activation of the RTK pathway has been linked to
carcinogenesis in mammals, underscoring the importance of preventing uncontrolled signaling. This review will focus on
the inhibitory mechanisms that keep RTK-mediated signals in check, with emphasis on conserved principles discerned from
studies using Drosophila as a model system. Two general strategies of inhibition will be discussed. The first, threshold
regulation, postulates that an effective way of antagonizing RTK signaling is to erect and maintain high threshold barriers
that prevent inappropriate responses to moderate signaling levels. Activation of the pathway above this level overcomes the
inhibitory blocks and shifts the balance to allow a positive flow of inductive information. A second layer of negative
regulation involving induction of negative feedback loops that limit the extent, strength, or duration of the signal prevents
runaway signaling in response to the high levels of activation required to surmount the threshold barriers. Such
autoinhibitory mechanisms attenuate signaling at critical points throughout the network, from the receptor to the
downstream effectors. © 2002 Elsevier Science (USA)
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The evolutionarily conserved receptor tyrosine kinase
(RTK) pathway is an extensively used intercellular signal
transduction mechanism that regulates cell fate specifica-
tion, differentiation, proliferation, migration, and survival.
RTKs comprise a large family of integral membrane pro-
teins with highly divergent extracellular domains coupled
to a conserved intracellular protein tyrosine kinase motif
(reviewed by van der Geer et al., 1994; Schlessinger, 2000).
This structure facilitates transduction of a diverse array of
extracellular signals via repeated use of common cytoplas-
mic signaling machinery. How reiterative deployment of
the same signaling cascade engenders specific and context-
appropriate cellular responses remains an area of intense
investigation.
In the last decade, genetic analyses in Drosophila and
Caenorhabditis elegans have combined with biochemicalTo whom correspondence should be addressed. Fax: (617) 258-
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and function of many key downstream components of the
RTK-mediated pathway (reviewed by Wassarman et al.,
1995; Perrimon and Perkins, 1997; Tan and Kim, 1999).
While several effector cascades have been implicated, this
review will focus exclusively on signaling via the Ras/
mitogen-activated protein kinase (MAPK) cassette. Signal
transduction through the RTK/Ras/MAPK pathway was
initially depicted as a linear flow of inductive information,
but is now more properly considered a complex interactive
network that interfaces both with itself and with other
signaling cascades (reviewed by Marshall, 1994, 1995; Gar-
rington and Johnson, 1999; Jordan et al., 2000; Peyssonnaux
and Eychene, 2001). This complexity reveals itself as mul-
tiple levels of autoregulatory and inhibitory controls that
fine-tune the timing and strength of RTK pathway activa-
tion (Perrimon and McMahon, 1999; Freeman, 2000).
The strict evolutionary conservation of the RTK pathway
validates the use of genetically tractable invertebrate model
systems to elucidate essential mechanistic principles that
apply generally among metazoa, including mammals (re-
1
viewed by Dickson and Hafen, 1994; Perrimon, 1994; Dick-
son, 1995; Tan and Kim, 1999). Through these studies, the
positive transduction of RTK-initiated signals from the
plasma membrane, through the cytoplasm, and to the
nucleus has been extensively characterized. However, the
mechanisms underlying signal down-regulation are only
beginning to be clarified (Perrimon and McMahon, 1999).
This review will summarize briefly the key contribution
that genetic screens in Drosophila have made toward elu-
cidating the components of the RTK signal transduction
network. The primary focus will be the inhibitory controls
and negative feedback loops that modulate RTK/Ras/
MAPK-mediated signals to promote context appropriate
cellular responses during Drosophila development.
OVERVIEW OF THE RTK/RAS/MAPK
CASSETTE
In response to ligand binding, dimerization of the RTK
induces trans- and auto-phosphorylation of specific tyrosine
residues on the C-terminal cytoplasmic tail of the receptor
(reviewed by Yarden and Ullrich, 1988; van der Geer et al.,
1994; Schlessinger, 2000). This modification generates
docking sites for a variety of phospho-tyrosine binding
(PTB) and Src-homology 2 (SH2) domain-containing adaptor
proteins. These in turn nucleate the assembly of specific
multiprotein complexes that activate downstream cyto-
plasmic signaling cascades (reviewed by Pawson and Scott,
1997).
In Drosophila, as in mammals, a primary consequence of
RTK stimulation is induction of a cytoplasmic signaling
relay mediated by the adaptor protein Downstream of
Receptor Kinase (DRK; known as GRB2 in vertebrates)
(Lowenstein et al., 1992; Olivier et al., 1993; Simon et al.,
1993). Upon binding to phosphotyrosine residues on the
RTK, DRK recruits the guanine nucleotide exchange factor
Son of Sevenless (SOS), which activates the GTPase RAS by
catalyzing the exchange of GDP for GTP. Like its mamma-
lian counterpart, Drosophila RAS functions as a molecular
switch whose on/off state is regulated by the binding and
hydrolysis of GTP (Bourne et al., 1991). In the GTP-bound
state, RAS recruits and activates the serine/threonine ki-
nase RAF in an intricate and not yet completely understood
process involving a host of kinases, phosphatases, and other
cytoplasmic proteins, including Kinase Suppressor of Raf
(KSR), Connector Enhancer of KSR (CNK), 14-3-3, HSP90,
Protein Phosphatase 2A (PP2A), and many others (reviewed
by Avruch et al., 1994, 2001; Kolch, 2000).
Once activated, RAF phosphorylates and activates MEK,
a dual-specificity tyrosine and serine/threonine MAPK ki-
nase (MAPKK). Activated MEK in turn phosphorylates and
activates extracellular regulated kinase (ERK), a member of
the MAPK superfamily (reviewed by Marshall, 1994; Seger
and Krebs, 1995; Robinson and Cobb, 1997; Kolch, 2000;
Peyssonnaux and Eychene, 2001). Since other MAPK family
members will not be discussed in this review, the generic
term MAPK will be used to refer specifically to ERK.
Activated MAPK has been shown to translocate from the
cytosol to the nucleus, where it phosphorylates and modu-
lates the activity of specific transcription factors (Marshall,
1995; Khokhlatchev et al., 1998; Robinson et al., 1998).
However, immunostaining with an antibody specific for the
activated diphosphorylated form of MAPK reveals both cyto-
plasmic and nuclear localization (Gabay et al., 1997a,b), cor-
roborating reports that cytoplasmic substrates also exist
(Lewis et al., 2000). Although the physiological significance of
most putative MAPK targets remains to be demonstrated, this
diverse collection of downstream effectors constitutes an
attractive solution to the problem of generating specific re-
sponses to RTK/Ras/MAPK signals (Lewis et al., 2000). Two
Drosophila E Twenty-Six (ETS) domain transcription factors,
POINTED (PNT) and YAN, are among the best characterized
MAPK targets and RTK pathway effectors, and will be dis-
cussed further below (Brunner et al., 1994; O’Neill et al., 1994;
Rebay and Rubin, 1995; Hsu and Schulz, 2000).
USING GENETIC MODIFIER SCREENS IN
DROSOPHILA TO IDENTIFY COMPONENTS
OF THE RTK SIGNALING NETWORK
Genetic analyses in Drosophila, particularly studies ex-
ploiting the fly eye as a model system, have been instru-
mental in revealing regulatory and hierarchical relation-
ships between signaling molecules (for example Rubin,
1991; Simon et al., 1991; Karim et al., 1996). The relation-
ships elucidated through these studies provide a paradigm
for RTK signaling that has been validated through genetic
and biochemical studies in other organisms, including
mammals.
The fly eye possesses several unique attributes that make
it a powerful system for studying signal transduction
mechanisms in vivo. Creation of the adult compound eye is
an inductive process requiring inputs from all major signal-
ing pathways. These events generate a highly ordered,
repeated array of unit eyes, or ommatidia, each of which
includes a stereotyped assembly of eight light sensing
photoreceptor neurons, designated R1–R8, and about a
dozen non-neuronal accessory cells (Tomlinson and Ready,
1987). Cells within each ommatidium are not clonally
related, but rather assume their specific identity based
exclusively on inductive cell signaling events (Ready et al.,
1976; Lawrence and Green, 1979). This feature makes the
eye ideally suited for exploring mechanisms of cross-talk
between signaling pathways and how repeated use of sig-
naling cassettes can specify a variety of distinct cell fates.
The first indication of a requirement for RTK signaling in
Drosophila eye development came from molecular analyses
of two mutants lacking the R7 photoreceptor neuron. One
these genes, sevenless (sev), encodes a transmembrane
receptor with tyrosine kinase homology in the intracellular
domain (Hafen et al., 1987). Genetic mosaic analyses dem-
onstrated that sev functions autonomously in the presump-
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tive R7 photoreceptor, and that loss of sev activity trans-
forms the R7 precursor into a non-neuronal cone cell
(Tomlinson and Ready, 1986; Tomlinson et al., 1987). The
second gene, bride-of-sevenless (boss), encodes a novel
multipass transmembrane protein expressed in the R8 cell
and required nonautonomously for R7 cell fate specification
(Reinke and Zipursky, 1988). These results led to the
hypothesis that BOSS protein expressed on the R8 cell
surface serves as an activating ligand for the SEV RTK
expressed on the adjacent presumptive R7 cell, and that the
ensuing signal transduction cascade promotes R7 cell dif-
ferentiation.
Based on this model, Simon et al. (1991) designed an
elegant genetic screen to identify downstream components
of the proposed SEV-mediated signaling pathway. The ap-
proach was to generate a weak sev mutant in which the
level of receptor activity was barely sufficient to allow R7
development. In this compromised background, a reduction
in the dose of a positive effector gene functioning down-
stream of SEV would almost eliminate signaling through
the pathway. Because perturbations in cell–cell signaling
during development alter the architecture of the compound
eye, new mutations that exacerbate or alleviate the sev
signaling imbalance can be isolated as visible modifiers of
the original phenotype. Furthermore, in this sensitized
system, heterozygous mutations that would otherwise be
completely wild-type, now exhibit dominant phenotypes.
This obviates the need to analyze homozygous mutant
animals, which are almost invariably embryonic lethal in
the case of conserved signaling molecules, and permits
screening to saturation with quick, single generation F1
crosses.
This screen was tremendously successful, isolating mu-
tations in the GTPase Ras, the adapter Drk, and the guanine
nucleotide exchange factor Sos (Simon et al., 1991, 1993).
These genes were shown also to function in the Drosophila
epidermal growth factor receptor (DER) pathway, providing
solid evidence that Ras-mediated signal transduction serves
as a major and common effector cascade downstream of
RTKs (Simon et al., 1991, 1993; Fig. 1). Strengthening this
argument, genetic studies of C. elegans vulval development
also implicated RAS as a key effector of RTK signaling
(Beitel et al., 1990; Han and Sternberg, 1990), and biochemi-
cal experiments in mammalian cultured cells have con-
firmed the broad conservation of RTK/RAS-mediated signal
transduction (van der Geer et al., 1994).
Simon et al.’s pioneering work inspired a series of highly
successful genetic interaction screens that continue to
isolate new components of the RTK pathway and to shed
light on feedback regulation and cross-talk with other
signaling pathways (for example, Dickson et al., 1996;
Karim et al., 1996; Rebay et al., 2000). While initial genetic
studies concentrated on signaling by the SEV RTK, which is
activated exclusively in the presumptive R7 cell, subse-
quent emphasis has been on the DER pathway which, in
addition to being required for each successive cell fate
determination event in the eye, also exerts pleiotropic
effects on virtually all tissues in the developing fly (Free-
man, 1996; Schweitzer and Shilo, 1997). It is beyond the
scope of this review to discuss this evolutionarily conserved
RTK/RAS/MAPK signaling module in its entirety. Rather,
the focus will be on the critical negative regulators that
keep the signaling cascade in check.
THE DROSOPHILA EPIDERMAL GROWTH
FACTOR RECEPTOR SIGNALING
PATHWAY
The epidermal growth factor receptor (EGFR) is perhaps
the most widely used RTK, controlling many aspects of
FIG. 1. The Drosophila EGFR signaling pathway. Interaction
between SPITZ and DER recruits a cytoplasmic complex of pro-
teins that includes DRK and SOS. This leads to activation of RAS,
RAF, MEK, and MAPK. Activated MAPK phosphorylates specific
proteins including the nuclear transcription factors PNT and YAN,
which in turn regulate expression of downstream target genes. See
text for details. Protein–protein interactions are shown as solid
black arrows; instances of transcriptional regulation are depicted as
dashed black arrows. The black rectangle depicts the plasma
membrane of a cell. The black oval represents the nucleus.
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growth, differentiation, and cell proliferation, with the
precise cellular response depending on the strength of
signal, the cell type receiving it, and the developmental
stage of the tissue (Marshall, 1995; Schweitzer and Shilo,
1997). How these different functions are specified, distin-
guished, and coordinated remains poorly understood. While
finely tuned pathway activity serves as a central effector of
normal cellular differentiation and development, inappro-
priate and continuous activation of the pathway provides a
potent and often catastrophic promitogenic force. This
causative link between mammalian cancer and misregula-
tion of the EGFR and its downstream signaling cascade
underscores the importance of negative regulation to pre-
vent inappropriate signaling (reviewed by Yarden and Ull-
rich, 1988; Porter and Vaillancourt, 1998).
Drosophila have a single EGFR, referred to as DER,
whereas humans have four, ErbB1–B4, (reviewed by Schles-
singer, 2000). Three classes of ligands, EGF, transforming
growth factor- (TGF-), and Neuregulin (NRG), bind to
and activate EGFRs (Yarden, 2001). The activating ligands
for DER include the TGF- family members SPITZ (Rut-
ledge et al., 1992; Tio et al., 1994) and GURKEN (Neuman-
Silberberg and Schupbach, 1993), and the NRG-like ligand
VEIN (Schnepp et al., 1996). Completion of the Drosophila
genome sequence has revealed the presence of an additional
SPITZ-like ligand called KEREN, although its function
remains to be elucidated (Bogdan and Klambt, 2001). Al-
though there are multiple instances of overlapping func-
tion, in general, GURKEN provides the major ligand during
oogenesis (Nilson, 1999), SPITZ fulfills this role during
embryogenesis and eye development (Perrimon and Per-
kins, 1997), and VEIN functions similarly during wing
development (Simcox, 1997). Designating ligands for dis-
tinct purposes likely contributes to signaling specificity
since variations in ligand-mediated receptor activation, and
by extension signaling strength, may effect different devel-
opmental outcomes (Perrimon and Perkins, 1997; Schnepp
et al., 1998). For example, the observation that VEIN
appears to activate DER weakly relative to SPITZ could
account for specific functional differences between the two
ligands in different developmental contexts (Golembo et
al., 1999).
The question of how reiterative use of DER signaling
elicits unique cell fate outcomes has been studied inten-
sively, particularly in the context of ommatidial assembly
during Drosophila eye development. DER signaling has
FIG. 2. Down-regulation of YAN and TTK-mediated inhibition in response to increased RTK activation. (a) RTK signaling below
threshold levels allows transcriptional repression by YAN and TTK and limits PNT’s ability to activate downstream targets. It is formally
possible that this scenario actually reflects the complete absence of MAPK signaling, rather than subthreshold levels as postulated. In
principle one could distinguish low levels versus absence of active MAPK by staining with a diphospho-specific anti-ERK antibody;
however, in practice, interpretation might be difficult due to the specificity and detection limitations of an antibody reagent. (b) Once
signaling exceeds this threshold, activated MAPK phosphorylates YAN, targeting it for down-regulation. This allows PNT to activate
expression of downstream target genes, including PHYL, which mediates down-regulation of TTK. Dismantling of both inhibitory blocks
ensures activation of appropriate downstream targets, including the negative feedback regulators ARGOS, KEK1 and SPROUTY. The list
of target genes is not intended to be complete and reflects only those regulated by YAN and PNT; little is known about possible targets of
TTK repression. It is also possible that certain target genes will be expressed at high levels under conditions of low signaling activity and
then turned off in response to increased pathway activation. The dashed arrows indicate transcriptional regulation; solid black arrows
indicate post-translational regulation.
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been implicated in the induction of all cell types, except R8
(Freeman, 1996, 1997). This suggests that cell fate is not
specified by the nature of the signal itself, but rather by the
developmental history and competence of each cell at the
time it receives the DER signal. Recent evidence suggests
that the current state of the cell, as determined by the sum
total of signaling events to which it has and is currently
being exposed, somehow provides critical information that
facilitates this process. Specifically, the different subsets of
transcription factors expressed as a result of exposure to
other signaling events will influence how any given cell
responds to RTK pathway activation (Flores et al., 2000; Xu
et al., 2000). Deciphering how the underlying signaling
networks modulate this combinatorial code of transcrip-
tional activators and repressors will be central to under-
standing how specific cellular outcomes are determined.
YAN AND TRAMTRACK: THRESHOLD
MODULATORS OF RTK SIGNALING
Proper regulation of signaling pathway activity involves
parallel processing of inductive influences and inhibitory
controls to ensure accurate and reproducible responses.
While traditionally greater emphasis has been placed on
elucidating the identity and function of positive signaling
elements, the pivotal role of inhibitory molecules has
recently become a topic of intense investigation. A funda-
mental outcome of inhibitory regulation is elevation of the
threshold for receptor activation and subsequent initiation
of the downstream signal transduction cascade. As a result,
the system responds only to the stronger peaks of activation
associated with specific developmental decision points,
while ignoring constitutive lower levels of signal that may
be required for cell survival and continuity of the differen-
tiation process.
The critical role that threshold modulation plays with
respect to RTK signaling is underscored by the presence of
two transcriptional repression mechanisms that block in-
appropriate differentiative responses to background levels
of pathway activation. These two checkpoint mechanisms
are mediated by the ETS-domain protein YAN, a broad
spectrum RTK pathway antagonist (Lai and Rubin, 1992),
and the Zn-finger protein Tramtrack (TTK), whose inhibi-
tory role has been best defined in neuronal tissues (Read and
Manley, 1992; Xiong and Montell, 1993). To prevent YAN
and TTK from blocking responses to the critical higher
intensity RTK stimuli, both proteins are down-regulated in
direct response to increased RTK-signaling, thereby reliev-
ing their inhibitory effects (Fig. 2; Rebay and Rubin, 1995;
Li et al., 1997; Tang et al., 1997).
yan was first postulated to act as an RTK-pathway
antagonist based on the finding that hypomorphic muta-
tions differentiate more than the normal complement of
photoreceptor neurons in each ommatidium of the devel-
oping retina (Lai and Rubin, 1992). This phenotype suggests
that compromised yan activity either upregulates RTK
signaling levels, or reduces the response threshold, leading
to inappropriate photoreceptor differentiation. Analyses in
embryonic and other tissues have shown that yan serves as
a general inhibitor of RTK-mediated signaling in Drosoph-
ila, functioning downstream of and negatively regulating
multiple RTK pathways (Rebay and Rubin, 1995; Rogge et
al., 1995). Depending on the particular developmental con-
text in which the RTK/Ras derived stimulus is received,
YAN mediates either the transition from an undifferenti-
ated to a differentiated cell state or the decision between
cell proliferation and differentiation. Thus, YAN activity
establishes a regulatory threshold that prevents cells from
responding to inductive or mitogenic signals. As a result,
context appropriate developmental responses to higher
spikes of RTK-initiated signaling require precisely timed
dismantling of YAN-mediated inhibition.
yan encodes an ETS-family transcriptional repressor that
competes with the transcriptional activator Pointed (PNT),
another ETS family RTK effector, for access to regulatory
regions of specific target genes (Lai and Rubin, 1992;
O’Neill et al., 1994). pnt encodes two alternatively spliced
products with a common DNA binding domain: a consti-
tutive activator termed PNT-P1 and an RTK-responsive
activator referred to as PNT-P2 (Klambt, 1993; Brunner et
al., 1994; O’Neill et al., 1994). According to the model,
proper balance between YAN-mediated transcriptional re-
pression and PNT-mediated transcriptional activation is
instrumental in determining specific outcomes to RTK
signaling. Upon increased RTK activation, down-regulation
of YAN-mediated repression, and in some cases concomi-
tant up-regulation of PNT-P2-mediated activation, ensues.
This allows PNT to prevail in the competition for promoter
access and turn on genes formerly repressed by YAN,
leading to appropriate differentiative or proliferative re-
sponses (Flores et al., 2000; Halfon et al., 2000; Xu et al.,
2000).
Experiments in cultured cells and in vivo have revealed
the basic events underlying YAN down-regulation, al-
though many of the details and interacting players remain
to be elucidated. In the absence of elevated RTK stimula-
tion, YAN resides in the nucleus, where it represses tran-
scription of its target genes (Lai and Rubin, 1992; Price and
Lai, 1999). In response to increased RTK stimulation, acti-
vated MAPK directly phosphorylates YAN (Brunner et al.,
1994). YAN contains multiple MAPK consensus sites, one
of which (Serine127) must be phosphorylated in order to
abrogate transcriptional repression in vitro (Baker et al.,
2001). In vivo analyses of transgenes containing various
mutant combinations of the multiple MAPK consensus
sites suggest that while phosphorylation of Serine127 is
necessary for down-regulation, phosphorylation at addi-
tional sites cooperatively enhances the process (Rebay and
Rubin, 1995).
Phosphorylation of Yan by MAPK at Serine127, and the
ensuing abrogation of YANs repressor activity, is thought
to be facilitated by a protein called Modulator of the
Activity of ETS (MAE) (Baker et al., 2001). MAE binds to
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YAN via a protein-protein interaction motif, referred to as
the Pointed Domain (PD) (Klambt, 1993) or Sterile  Motif
(SAM) (Ponting, 1995), that is found at the N terminus of
Yan and the C terminus of MAE. Interestingly, while ETS
family transcription factors are generally believed to bind
DNA as monomers (Werner et al., 1995; Kodandapani et al.,
1996; Pio et al., 1996), mounting evidence suggests that
formation of functional homo- and heteropolymers, medi-
ated by the PD’s self-association ability, may also occur
(Jousset et al., 1997). Both YAN and its closest human
orthologue, a transcriptional repressor called TEL, have the
ability to dimerize via their PDs (Jousset et al., 1997; I.R.,
unpublished observations). Although the implications of
YAN–YAN association in Drosophila are unclear, studies
of TEL have demonstrated that dimerization through the
PD is necessary for repressor activity in vitro (Jousset et al.,
1997; Kim et al., 2001). Consistent with this finding,
structural studies of TEL’s PD suggest it has the ability to
form large polymers that potentially could mediate the
spreading of transcriptional repression complexes on the
DNA (Kim et al., 2001). Alternatively, efficient transcrip-
tional repression at a specific promoter might be facilitated
by coordinate binding of a cluster of ETS recognition sites
by TEL (or YAN) polymer.
In addition to abrogating YANs repressor activity di-
rectly, phosphorylation by MAPK leads to nuclear export of
YAN, thereby preventing resumption of transcriptional
repression (Tootle and I.R., manuscript submitted). Experi-
ments in S2 cultured cells in which activation of Ras/
MAPK leads to accumulation of phosphorylated YAN in
the cytoplasm first suggested this mechanism (Rebay and
Rubin, 1995). However, in Drosophila tissues where YAN
down-regulation is essential for differentiation, cytoplas-
mic buildup of YAN has not been detected; rather, nuclear
YAN expression simply disappears in vivo (Lai and Rubin,
1992; Price and Lai, 1999). This apparent discrepancy sug-
gests that either the cultured cell result is an artifact, and
nuclear export is not a relevant part of YAN downregula-
tion, or that in vivo, rapid removal of cytoplasmic YAN
occurs via a mechanism lacking in the S2 cell system.
Our recent results favor the second interpretation. We
have verified that nuclear export is essential for YAN
downregulation and demonstrated that YAN is exported by
the LeptomycinB-sensitive Crm1/exportin-mediated path-
way both in cultured cells and in vivo (Tootle and I.R.,
manuscript submitted). The mechanism underlying degra-
dation of cytoplasmic YAN remains unknown, although
the presence of numerous PEST sequences in the protein
has led to speculation that degradation is likely mediated by
ubiquitination and subsequent targeting to the proteasome
(Lai and Rubin, 1992; Rebay and Rubin, 1995). Because
proteasome function has been demonstrated in S2 cultured
cells, as in the case of TTK regulation described below (Li et
al., 1997), the accumulation of cytosolic YAN likely indi-
cates the absence of a critical cofactor(s) required for target-
ing YAN to the degradation machinery.
Tramtrack encodes two alternatively spliced zinc-finger
transcriptional repressors, termed TTK69 and TTK88 (Read
and Manley, 1992). The two isoforms share a BTB/POZ
motif that mediates protein–protein interactions but have
distinct DNA binding domains, suggesting they regulate
different target genes (Fairall et al., 1992). Both isoforms
function as negative regulators of the RTK pathway and
both are targeted by RTK signaling for degradation (Xiong
and Montell, 1993; Li et al., 1997; Tang et al., 1997; Lai and
Li, 1999; Lehembre et al., 2000; Wen et al., 2000). For
example, expression of TTK69 and TTK88 is normally
undetectable in the differentiating photoreceptor neurons,
but is present in the undifferentiated cells and in the
non-neuronal cone cells, where it inhibits them from adopt-
ing a neural fate (Li et al., 1997). Consistent with this,
overexpression of either TTK88 or TTK69 blocks photore-
ceptor recruitment, consistent with both isoforms opposing
RTK signaling and inhibiting neuronal development. Inter-
estingly, TTK69 also appears to play a positive role in
photoreceptor development during later pupal stages (Lai
and Li, 1999).
Similar to YAN, TTK-mediated inhibition of low level
RTK signaling is attenuated in response to a spike of RTK
activation. Two primary cofactors have been implicated (Li
et al., 1997; Tang et al., 1997): one of these, phyllopod
(phyl), encodes a novel nuclear protein required for R1, R6,
and R7 fate determination as well as for embryonic periph-
eral nervous system (PNS) development (Chang et al., 1995;
Dickson et al., 1995); the second, seven-in-absentia (sina),
encodes a ring finger containing nuclear protein (Carthew
and Rubin, 1990). SINA and PHYL bind directly to TTK,
and cooperatively mediate its ubiquitination and subse-
quent degradation by the proteasome (Li et al., 1997; Tang
et al., 1997). A third gene product, EBI, an evolutionarily
conserved protein with an F-box-related sequence at its N
terminus and WD40 repeats at the C terminus, physically
interacts with SINA and PHYL to facilitate this process
(Dong et al., 1999).
Transcription of phyl is upregulated in response to Ras/
MAPK signaling, suggesting that phyl is likely to be one of
the direct targets for POINTED and YAN (Chang et al.,
1995; Dickson et al., 1995). Thus, YAN may antagonize
RTK signaling in part by repressing phyl expression,
thereby stabilizing TTK levels. Increased RTK signaling
dismantles the TTK88-mediated repressive mechanism
through concomitant downregulation of YAN and upregu-
lation of PNT. This leads directly to transcriptional induc-
tion of phyl, degradation of TTK, and ultimately assump-
tion of a neuronal fate.
The importance of dismantling inhibitory checkpoints in
a timely manner is underscored by the efficient RTK-
responsive posttranslational mechanisms that rapidly re-
move YAN and TTK proteins from the nucleus (Rebay and
Rubin, 1995; Li et al., 1997; Tang et al., 1997). Because such
signals are likely to be transient, mechanisms either to
degrade or to block translation of the existing transcripts as
well as more long term, active transcriptional inhibition of
yan and ttk expression may be required to stabilize the
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response. While purely speculative at this point, several
interesting models can be considered. The gene split ends
(spen), which encodes the founding member of a novel
family of putative RNA binding proteins, was isolated in a
yan-based genetic screen, and shown to function as a
positive regulator or effector of RTK signaling (Chen and
Rebay, 2000; Rebay et al., 2000). Thus, one possibility is
that SPEN could directly bind to yan and/or ttk transcripts,
thereby reducing stability or translation in response to RTK
signaling.
Another efficient strategy for stably repressing yan and/or
ttk transcription would be for PNT and YAN to reverse
their normal roles, and for PNT to act as a context-specific
repressor and YAN to serve as an activator (Fig. 2). Accord-
ing to this model, partial PNT-mediated repression of yan
and/or ttk under low signaling conditions would prevent
FIG. 3. Multiple strategies for negatively regulating DER signaling. An abbreviated version of the DER/RAS/MAPK signaling cascade
depicts only those proteins targeted for inhibitory regulation as discussed in the text. Positive feedback loops are not illustrated. The two
parallel horizontal black lines depict the plasma membrane, with the extracellular space above and the cytoplasm of the cell below. The
black oval encircling PNT and YAN represents the nucleus. Black arrows depict protein–protein interactions; dashed arrows indicate
transcriptional regulation.
7Receptor Tyrosine Kinase Signaling in Drosophila
© 2002 Elsevier Science (USA). All rights reserved.
the buildup of insurmountable inhibitory thresholds. A
second prediction is that in order to prevent premature
dismantling of the inhibitory blocks, YAN would activate
its own and/or ttk transcription. Thus competition between
YAN and PNT, just as it contributes to downstream signaling
specificity, would play a key role in fine-tuning the level of
pathway inhibition. In response to increased RTK stimula-
tion, PNT would completely block yan and/or ttk transcrip-
tion, stabilizing down-regulation. Supporting such a model,
Rohrbaugh et al. (2002) report that PNT binds specifically to a
yan enhancer element and represses its transcription. Surpris-
ingly, the same study suggests that YAN also represses, rather
than activates, its own transcription, setting up an autoinhibi-
tory mechanism that limits the amount of YAN produced
(Rohrbaugh et al., 2002). Although complete understanding of
the in vivo significance and usage of these regulatory mecha-
nisms requires further investigation, the results underscore
the importance that precisely tuned inhibitory threshold lev-
els play in preventing inappropriate cellular responses to RTK
signaling.
In conclusion, YAN and TTK are both examples of RTK
inhibitors whose activity is down-regulated in response to the
same pathway they antagonize. For such regulation to work,
one must hypothesize different thresholds of RTK signaling
having different effects, either directly or because specific
cellular conditions alter the outcome. In either case, YAN and
TTK effectively counteract only a certain level of RTK signal-
ing. Once the pathway is activated beyond this threshold, the
inhibitory blocks are overcome and the balance shifts to allow
a positive flow of inductive information.
FIG. 4. ARGOS and KEK1 antagonize DER signaling in the follicle cells to pattern the dorsal appendages. A section of dorsal anterior
follicle cells is depicted as a stripe of colored boxes. Not shown is the initial GURKEN-mediated signal from the oocyte that initiates DER
activation at the dorsal anterior midline (position of dark blue box). Subsequent positive feedback loops expand DER activation laterally
(light blue boxes). (a) As a result, in a wild type oocyte, highest levels of DER activation are found in the midline follicle cells (dark blue
box), while moderate levels of activation occur laterally (light blue boxes). KEK1-mediated antagonism restricts the domain of DER
activation, preventing excessive lateral spread (white boxes). ARGOS activation is restricted to cells at the midline, where DER signaling
is at a maximum, and attenuates signaling in this region (white boxes in middle). This leaves two lateral patches of moderate DER
activation (light blue boxes), which ultimately give rise to the dorsal chorionic appendages, shown in blue in the schematic representation
of the oocyte. (b) Loss of argos leads to a failure to split the initial DER activation peak into two, resulting in a single or fused appendage.
(c) Loss of kek1 allows DER signaling to spread laterally, leading to increased separation between the two dorsal appendages.
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SIGNAL ATTENUATION AND NEGATIVE
FEEDBACK REGULATION
A precise balance between amplification and attenuation
allows for dynamic regulation of signaling pathway output
(Freeman, 2000). While both stimulatory and inhibitory
feedback loops play key roles in modulating RTK signaling,
this section will focus on the autoinhibitory mechanisms
that downregulate pathway activity. Negative feedback
regulation, the process whereby induction of an inhibitory
molecule attenuates signaling of the same pathway that
activates it, exquisitely controls signaling output through
constant monitoring of pathway activity (Perrimon and
McMahon, 1999). The resulting quantitative variations in
activity levels of RTK/Ras/MAPK cascade components,
from the receptor down to the transcriptional effectors, are
integral in imparting specificity to the cellular response.
Directly targeting the receptor represents an effective
strategy to attenuate the strength and duration of RTK
pathway activation. Two inhibitory feedback loops that
moderate DER signaling by preventing productive receptor–
ligand interactions will be discussed. In addition, several
examples from a growing collection of inhibitory molecules
that regulate the downstream signaling network will be
presented. These examples are not intended to be all-
inclusive, but rather to illustrate the different strategies
employed to attenuate and temper signaling levels within
the RTK network (Fig. 3). By fine-tuning signaling at mul-
tiple points in the pathway, these nested layers of inhibi-
tory controls ensure that RTK activation never triggers a
runaway response.
ARGOS AND KEKKON
Direct abrogation of receptor activity by the argos gene
product has been characterized in multiple developmental
contexts, including the embryonic ventral ectoderm, the
midline glial cells, the wing vein precursors, the dorsal
follicle cells in the oocyte (see below), and the photorecep-
tor cells of the eye (Schweitzer et al., 1995; Golembo et al.,
1996; Stemerdink and Jacobs, 1997). argos encodes a se-
creted protein structurally related to the DER activating
ligands; however, ARGOS–DER interactions inhibit, rather
than activate, DER signaling (Freeman et al., 1992). ARGOS
binds directly to the extracellular domain of DER, thereby
preventing receptor dimerization and subsequent activation
of the downstream signaling cascade (Howes et al., 1998; Jin
et al., 2000; Vinos and Freeman, 2000).
Perhaps the most interesting feature of argos-mediated
antagonism is that its expression is induced in response to
high levels of DER activation (Golembo et al., 1996).
Because it encodes a diffusible secreted protein, argos
nonautonomously down-regulates DER signaling over a
field of cells, presumably establishing a gradient of signal
attenuation that contributes to patterning of the developing
tissue. For example, in the eye, argos expression is induced
repeatedly in response to sequential DER activation in each
developing cell type. Expression of PNT has been shown to
induce argos expression both in cell culture and in vivo,
suggesting argos is a direct transcriptional target of PNT
and YAN (Golembo et al., 1996). If true, one would predict
argos induction to have a high DER signaling threshold,
similar to that required to inactivate YAN. In vivo experi-
mentation has confirmed that argos is induced only at sites
of maximal DER activation (Wasserman and Freeman,
1998).
A second negative feedback loop that attenuates DER
signaling is mediated by the gene kekkon-1 (kek1). Kek1
encodes a single pass transmembrane protein with both
leucine-rich repeats and immunoglobulin motifs in the
extracellular domain (Musacchio and Perrimon, 1996). Loss
of kek1 results in increased DER signaling, while overex-
pression blocks DER activity (Ghiglione et al., 1999). Like
argos, kek1 expression is induced in response to DER
activation and KEK1 physically interacts with the receptor
to block signaling. Possible mechanisms of inhibition in-
clude hindering DER interaction with activating ligands,
preventing receptor dimerization, inhibiting the cytoplas-
mic domain of DER from becoming tyrosine phosphory-
lated, or targeting the receptor for internalization and
degradation. Unlike argos, which encodes a secreted mole-
cule with a non-cell-autonomous range of function, kek1
down-regulates DER signaling in a cell autonomous man-
ner.
Why does attenuation of DER signaling require induction
of two separate feedback loops that directly target the
receptor? Are these mechanisms redundant, or do they
serve distinct purposes? Studies of DER signaling in the
developing oocyte have been particularly informative in
resolving these issues. DER signaling is required for mul-
tiple aspects of oogenesis, including specification of the
embryonic axes and patterning of the chorion, or eggshell
(Perrimon and Perkins, 1997; Sapir et al., 1998; Wasserman
and Freeman, 1998). The receptor is expressed uniformly in
the somatic follicle cell epithelium that surrounds the
developing oocyte, and is activated differentially by local-
ized production of the ligand GURKEN in the oocyte
(Nilson, 1999). DER is activated first in the posterior follicle
cells and later in the dorsal–anterior follicle cells, thereby
establishing axial polarity of the oocyte, and ultimately the
embryo.
It is in the context of differentiation and patterning of the
dorsal anterior follicle cells, specifically those that will give
rise to the two chorionic respiratory appendages, that an
autoregulatory cascade of signal amplification and attenu-
ation is revealed (Fig. 4; Wasserman and Freeman, 1998;
Nilson, 1999). In the absence of DER signaling, the dorsal
appendages are not specified; if DER is ectopically acti-
vated, the appendages can be repositioned. As both argos
and kek1 are DER antagonists, both genes exhibit loss-of-
function phenotypes consistent with unregulated receptor
signaling. However, the phenotypes are not identical, sug-
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gesting the two genes are not redundant (Wasserman and
Freeman, 1998; Ghiglione et al., 1999).
The current model proposes that oocyte-derived GURKEN
activates DER in the dorsal follicle cells (Wasserman and
Freeman, 1998). This signal is amplified locally among the
dorsal follicle cells through a positive feedback loop involving
enhanced production of the activating ligand SPITZ. kek1 is
induced broadly and restricts the lateral spreading of DER
activation (Ghiglione et al., 1999). This is revealed by kek1
mutants, in which bilateral expansion of the DER activation
domains results in enhanced spacing between the two dorsal
appendages. Induction of argos on the other hand, primarily
occurs at the midline where DER activation is maximal. By
attenuating signaling at the midline, argos effectively splits
the initial signal into two distinct peaks of activation that
define the domains where the dorsal appendages will form.
Thus, argos mutants have fused appendages, reflecting a
failure to suppress DER signaling in the dorsal midline follicle
cells. Mathematical modeling of the GURKEN–DER–ARGOS
regulatory system has recently substantiated the original
genetic model as providing a robust explanation for all aspects
of the biological phenomena (Shvartsman et al., 2002).
Interestingly, pnt, generally considered a positively act-
ing factor in the RTK pathway, in this context, based on
both loss-of-function and overexpression phenotypes, ap-
pears to antagonize DER signaling (Morimoto et al., 1996).
One possible explanation is that the primary function of pnt
in the dorsal follicle cells may be induction of the inhibi-
tory ligands argos and kek1.
CBL
Since RTK activation involves dimerization and auto-
phosphorylation of the receptor’s intracellular domain, sig-
nal attenuation is also effected by proteins that interact
with the cytoplasmic tail of the receptor. For example, a
host of protein tyrosine phosphatases have been implicated
in negatively regulating RTK activation and signaling.
However, this subject has been recently reviewed (Ostman
and Bohmer, 2001) and will not be discussed here.
Mammalian cultured cell systems have been used to
study another downregulation mechanism involving endo-
cytosis and recycling of the RTK. Ligand-induced receptor
endocytosis can either target the receptor for ubiquitin-
mediated degradation, or alternatively promote association
with specific downstream effectors in endocytic compart-
ments (reviewed by Clague and Urbe, 2001). CBL proteins,
E3 ubiquitin ligases that are activated by tyrosine phosphor-
ylation in response to growth factor stimulation, have been
proposed to downregulate EGFR signaling by increasing the
rate of internalization and turnover of the activated recep-
tor (Levkowitz et al., 1998). In addition, CBL regulates
receptor endocytosis and sorting in the early endosome.
Genetic studies in C. elegans and Drosophila have con-
firmed CBL’s role as a DER antagonist in multiple develop-
mental contexts (Meisner et al., 1997; Pai et al., 2000).
Biochemical analyses suggest CBL functions as an adaptor
protein capable of binding to an assortment of key signaling
proteins including GRB2 and SPROUTY, although the
functional significance of these interactions remains un-
clear (Wong et al., 2001).
SPROUTY
In addition to inhibitory mechanisms that directly target
the receptor, several strategies exist to limit activity of the
downstream signaling cascade. Sprouty was originally iden-
tified as an inhibitor of the fibroblast growth factor (FGF)
RTK signaling pathway during tracheal branching in the
Drosophila embryo (Hacohen et al., 1998). It was shown
subsequently to antagonize DER in the eye, wing, and
oocyte, suggesting it functions as a general inhibitor of RTK
signaling (Casci et al., 1999; Kramer et al., 1999; Reich et
al., 1999). sprouty expression is induced upon RTK activa-
tion, providing evidence for another negative regulatory
loop (Casci et al., 1999). For example, during oogenesis,
sprouty induction is observed in all follicle cells in which
DER activation occurs and appears to uniformly attenuate
signaling (Ghiglione et al., 1999).
Sprouty encodes the founding member of a family of
cysteine-rich, membrane-associated proteins found in both
invertebrates and mammals (Hacohen et al., 1998). Some
controversy remains as to whether SPROUTY functions
intra- or extracellularly, or both (Hacohen et al., 1998; Casci
et al., 1999). Genetic studies suggest Sprouty acts down-
stream of the receptor but upstream of Ras, while in vitro
biochemical analyses have demonstrated direct binding to
the adaptor proteins DRK and GAP1 (Casci et al., 1999).
Together these results suggest that SPROUTY-mediated
inhibition of RTK signaling may occur through interference
with RAS activation, although the physiological relevance
of this model remains to be demonstrated (Gross et al.,
2001; Wakioka et al., 2001).
GAPs AND GEFs
A precise balance between the “on” and “off” state of
RAS, mediated by GEF and GTPase activating protein
(GAP) activity, respectively, determines the strength and
duration of RAS-mediated signals (reviewed by Bollag and
McCormick, 1991; Boguski and McCormick, 1993). How
this is achieved remains to be elucidated, although it will
presumably involve dynamic regulation of GEF and GAP
activity. For example, MAPK-mediated phosphorylation of
SOS negatively regulates its GEF activity, thereby damping
RAS activity and the downstream signaling response (Buday
et al., 1995).
GAP proteins down-regulate RAS activity by stimulating
GTPase activity and hence a return to the inactive GDP-
bound state (reviewed by Bollag and McCormick, 1991;
Boguski and McCormick, 1993). Drosophila orthologues of
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the three types of mammalian GAPs have been identified.
The first, Gap1, appears to function specifically in the eye,
suggesting other GAP family members regulate RAS in
most other developmental contexts (Gaul et al., 1992). The
second, p120 RasGAP, is likely to serve this more general
role, since it is expressed ubiquitously throughout develop-
ment (Feldmann et al., 1999). Consistent with this hypoth-
esis, RasGAP has been shown to antagonize multiple RTKs
in different developmental contexts. Loss-of-function mu-
tations in Neurofibromatosis type 1 (NF1), the third type of
GAP, increase Ras activity in several mammalian tumor
cell types (Cichowski and Jacks, 2001; Lakkis and Tennek-
oon, 2001). However, Drosophila NF1 mutants do not
exhibit phenotypes in the embryo or eye that would be
consistent with function downstream of RTK signaling
(The et al., 1997). This could be due to partial redundancy
between NF1 and the other GAP proteins with respect to
Ras regulation. Interestingly, NF1 has been shown to signal
through the RAS/MAPK cascade in the context of the
circadian clock (Williams et al., 2001). Nf1 mutants exhibit
abnormal circadian rhythm and have increased MAPK
activity in Drosophila, suggesting NF1 antagonizes the RAS
pathway in this context.
Attributing distinct Ras-regulatory roles to each of the
GAP proteins is likely to be complicated by functional
redundancy. Proteomic approaches that follow the dynam-
ics of multiprotein signaling complexes during develop-
ment, or combinatorial knock-downs of the GAPs via
RNAi, may provide a solution to this problem.
MAPK PHOSPHATASES
Activation of MAPK is the key event downstream of Ras
that bridges the gap between cytoplasm and nucleus (re-
viewed by Kolch, 2000). Given this essential function,
FIG. 5. Antagonistic cross-regulation between the DER and NOTCH pathways. Several possible mechanisms of antagonism between DER
and NOTCH are depicted. Integration of parallel activity of the two pathways, with DER transducing positive inductive information,
depicted as a “Go” signal on a traffic light, and NOTCH inhibiting differentiation, depicted as a “Stop” signal, may occur at the level of
combinatorial regulation of downstream target genes. Direct cross-talk may be mediated via NOTCH activation transcriptionally inducing
yan, and thereby raising the threshold for DER signaling. Another mechanism of cross-talk involves NOTCH responsive transcriptional
induction of a MAPK phosphatase (MKP), which inactivates MAPK and attenuates downstream signaling. Future work will likely uncover
additional mechanisms of direct cross-regulation between the two pathways.
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regulation of timing, strength and duration of MAPK activ-
ity is likely to be a critical determinant of signaling speci-
ficity. In fact, inactivation of MAPK by phosphatases has
emerged as a critical strategy for controlling signal output
(Clarke, 1994; Keyse, 2000; Ostman and Bohmer, 2001).
Biochemical studies in mammalian cell culture have shown
that dual-specificity phosphatases, such as MKP-1 and
MKP-3, dephosphorylate and inactivate MAPK (Camps et
al., 1998). MKP-3 is induced in response to MAPK activa-
tion and specifically recognizes cytoplasmic MAPK,
thereby limiting the pool of activated cytosolic MAPK.
PTP-ER, a novel tyrosine phosphatase identified in a Dro-
sophila genetic screen as a negative regulator of Ras signal-
ing, binds to and dephosphorylates Drosophila MAPK,
thereby abrogating its activity (Karim and Rubin, 1999).
PTP-ER appears to be constitutively expressed, at least in
cell culture, and does not appear to be induced in response
to RTK activation. Interestingly, PTP-ER contains a dock-
ing site for MAPK, multiple potential MAPK phosphoryla-
tion consensus sites, and is phosphorylated by MAPK in
vitro. Together, these observations suggest PTP-ER may be
subject to direct MAPK-mediated regulation.
OTHERS
Genetic and phenotypic studies have identified other
putative negative regulators of RTK signaling. These genes
were isolated either based on a loss-of-function phenotype
in the eye in which supernumerary photoreceptors develop,
and/or via genetic interactions with RTK pathway compo-
nents that are suggestive of an antagonistic role. For most,
the precise interface with the RTK signaling cascade re-
mains to be elucidated. The list of possible antagonists
includes, but is not limited to, the putative cell adhesion
molecules ECHINOID (Bai et al., 2001) and SIDEKICK
(Nguyen et al., 1997), the deubiquitinase FAT FACETS and
its substrate LIQUID FACETS (Isaksson et al., 1997; Chen
et al., 2002), the transcriptional corepressor GROUCHO
(Price et al., 1997), the cell cycle regulator STRING (Rebay
et al., 2000), and a novel PHD class Zn finger protein named
RHINOCEROS (Voas and I. R., manuscript in preparation).
CROSSTALK WITH OTHER SIGNALING
PATHWAYS
Proper modulation of RTK signaling requires not only
autoregulatory feedback loops, but also interactions with
other signaling pathways, creating an intricate web of
molecular events that culminates in context appropriate
developmental responses. Genetic analyses in Drosophila
have provided some hints as to the nature of these interac-
tions although the precise molecular links remain elusive.
A comprehensive overview of interactions between the
RTK and other signaling pathways is beyond the scope of
this review and will be presented elsewhere (Voas and I.R.,
manuscript in preparation). Instead, we will provide a brief
overview of antagonistic interactions between the RTK
(primarily DER) and NOTCH signaling pathways in Dro-
sophila as an illustrative example of emerging principles
underlying pathway cross-talk (Fig. 5).
Like DER, NOTCH signaling is required reiteratively,
contributing to virtually all developmental processes in the
fly (reviewed by Artavanis-Tsakonas et al., 1999). Genetic
studies have demonstrated a generally antagonistic rela-
tionship between NOTCH and DER in multiple contexts,
including wing vein formation (de Celis and Bray, 1997), eye
specification (Verheyen et al., 1996; Price et al., 1997;
Miller and Cagan, 1998; Kumar and Moses, 2001), embry-
onic mesoderm development (Carmena et al., 2002), and
peripheral nervous system development (zur Lage and Jar-
man, 1999; Culi et al., 2001), although the two pathways
also appear to synergize in certain circumstances (Price et
al., 1997). While the molecular links underlying these
interactions are just beginning to be elucidated, the emerg-
ing theme is that DER signaling generally induces cell fate
commitment within a tissue, whereas NOTCH activation
inhibits this commitment.
One intriguing model stems from the observation that
the consequences of activating the NOTCH receptor are
highly reminiscent of the phenotypes associated with con-
stitutive activation of the RTK antagonist and effector YAN
(Fortini et al., 1993; Rebay and Rubin, 1995). Specifically,
activation of either NOTCH or YAN delays differentiation,
thereby maintaining developmental competence (Fortini et
al., 1993; Rebay and Rubin, 1995). A recent report by
Rohrbaugh et al. (2002) suggests that transcriptional induc-
tion of yan in response to NOTCH activation provides at
least a partial explanation for the antagonistic relationship
between NOTCH and DER signaling. Specifically, the au-
thors show that SUPPRESSOR OF HAIRLESS [SU(H)], a
NOTCH pathway transcriptional effector, directly binds
and activates a yan enhancer element (Rohrbaugh et al.,
2002). Thus activation of NOTCH, by transcriptionally
inducing yan, and potentially increasing the pool of active
YAN repressor, may directly raise the threshold for RTK
signaling.
A second model proposes that cross-talk will be mediated
by a combinatorial code of transcriptional activators and
repressors whose activity is regulated directly by these
signaling pathways. This principle has been illustrated
elegantly in the context of the eye and embryonic meso-
derm, where integration of Notch and DER signals, together
with other transcription factors, delimits the code that
determines cell fate identity (Flores et al., 2000; Halfon et
al., 2000; Carmena et al., 2002). Such models position the
two signaling pathways more or less in parallel with their
individual outputs integrated at the end on specific target
gene promoters (reviewed by Simon, 2000).
These two models are unlikely to represent the only
mechanistic links between the NOTCH and RTK path-
ways. For example, recent work from C. elegans suggests
NOTCH activation transcriptionally induces a potent
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MAPK phosphatase, and that this may also be an important
mechanism for efficiently attenuating signaling down-
stream of EGFR (Berset et al., 2001). SU(H) may also
activate expression of tissue or cell-type specific repressors
other than YAN, such as those of the ENHANCER OF
SPLIT complex, to block expression of common target
genes (Culi et al., 2001). In addition, evidence exists that
NOTCH signaling may block the positive feedback loops
that normally amplify RTK signaling and that this may
involve synergistic interactions between the NOTCH li-
gand DELTA and the EGFR antagonist ARGOS (Carmena et
al., 2002). Finally, further complexity with respect to
NOTCH-RTK antagonism has been illustrated in the con-
text of lateral inhibition, where upregulation of NOTCH
ligand expression in response to RTK/RAS signaling rein-
forces the lateral inhibitory signal that leads to downregu-
lation of RAS activity in adjacent cells (Levitan and Green-
wald, 1998; Ikeya and Hayashi, 1999; Carmena et al., 2002).
The complete answer will likely include parallel signal
integration as well as direct cross-regulation of signaling
molecules between the NOTCH and RTK pathways (Car-
mena et al., 2002; Rohrbaugh et al., 2002).
CONCLUSIONS
In summary, the RTK signaling network contributes to
almost every aspect of cellular growth and differentiation,
interfacing both with itself and with other key signaling
pathways. We are just beginning to understand the com-
plexities of regulation, namely how reiterative use of a
common signaling cascade can induce such pleiotropic, yet
context appropriate cellular responses. In the future,
genomic and proteomic tools will provide powerful new
methods for dissecting the intricacies of these signaling
networks. For example, knowledge of the specific down-
stream transcriptional effectors associated with a target
promoter at any point in development will provide a blue-
print for deciphering the combinatorial signaling code that
regulates specific outcomes. In additional to transcriptional
control, an essential aspect of pathway regulation involves
posttranslational modification of protein function. As we
strive to decipher the intricacies of RTK signaling and
regulation, it is important to remember that the positive
signals that drive a process forward, and the negative
checkpoints that prevent inappropriate cellular responses,
are equally important in achieving a precisely tuned signal-
ing balance. Model organisms such as Drosophila, in which
the intricacies of genetic networks can be dissected at the
resolution of a single cell, will remain invaluable for testing
the physiological relevance of emerging hypotheses.
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